Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 68084-415

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68084-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp31001

Divalproex Sodium 250 mg or 500 mg extended-release film-coated oral tablets from American Health Packaging. The image shows an oblong white tablet with the imprint 'ZA47' on one side and plain on the other side.*

FDA Label Image

Ahp041501

Divalproex Sodium 250 mg or 500 mg extended-release film-coated tablet, oval white, imprinted with 'ZA48' on one side; the other side is plain. Manufactured by American Health Packaging for oral administration.*

FDA Label Image

Structural Formula (Structure)

Chemical structure diagram of divalproex sodium, showing its molecular composition and arrangement of atoms.*

FDA Label Image

Figure 1 (Figure 1)

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium delayed-release tablets and placebo. The x-axis represents the percentage of patients, and the y-axis shows the percentage reduction in CPS rate, indicating improvement above zero and worsening below zero. The solid line represents Divalproex Sodium delayed-release tablets, and the dashed line represents placebo.*

FDA Label Image

Figure 2 (Figure 2)

A cumulative distribution plot showing the percent reduction in CPS rate versus the percent of patients for high dose and low dose Divalproex Sodium delayed-release tablets. The y-axis ranges from -100% (worsening) to 100% (improvement), with a zero line indicating no change. The x-axis represents percent of patients from 0 to 100%. Two lines, one solid for high dose and one dashed for low dose, track patient response.*

FDA Label Image

Figure 3 (Figure 3)

A bar chart comparing two groups: Placebo and Divalproex Sodium Extended-release Tablets. The chart shows a higher value for the Divalproex Sodium group (1.2) compared to the Placebo group (0.6), with a noted p-value of 0.006 indicating statistical significance.*

FDA Label Image

250 mg Divalproex Tablets Carton.jpg (250 mg Divalproex Tablets Carton)

Label for Divalproex Sodium extended-release tablets USP, 250 mg strength, film-coated and designed for once-daily oral dosing. The package contains 100 tablets (10 blister packs of 10). Labeler is American Health Packaging, with prescribing information accessible via QR code. The label includes directions for pharmacists and storage instructions at controlled room temperature.*

FDA Label Image

250 mg Divalproex Tablet Blister.jpg (250 mg Divalproex Tablet Blister)

Label for Divalproex Sodium 250 mg extended-release film-coated tablets. The label shows product name, strength, dosage form, and manufacturer American Health Packaging, including lot and expiry date placeholders, barcodes, and standardized packaging information. The layout repeats multiple identical labels.*

FDA Label Image

500 mg Divalproex Tablets Carton 10x10.jpg (500 mg Divalproex Tablets Carton 10x10)

Divalproex Sodium Extended-release 500 mg tablets, USP, film-coated, extended-release oral tablets. The label indicates a once-daily dosing regimen and contains 100 tablets (10 x 10) packaged by American Health Packaging. The label includes NDC 68084-415-01, storage instructions, dispensing notes for pharmacists, and a QR code for medication guide and prescribing information.*

FDA Label Image

500 mg Divalproex Tablet Blister 10.jpg (500 mg Divalproex Tablet Blister 10)

Labels for Divalproex Sodium Extended-release Tablets, USP, 500 mg strength. Each label includes identifiable barcodes, expiration dates, lot numbers, and American Health Packaging as the labeler, located in Columbus, Ohio. The labels specify once-daily dosing for oral administration in film-coated extended-release tablet form.*

FDA Label Image

500 mg Divalproex Tablets Carton 10x8.jpg (500 mg Divalproex Tablets Carton 10x8)

Divalproex Sodium Extended-release Tablets, USP 500 mg, film-coated, extended-release oral tablets. The label indicates once-daily dosing with a total of 80 tablets (10 blister packs of 8 tablets each). The product is labeled for prescription use only and distributed by American Health Packaging. It includes instructions to dispense the medication guide to patients and has a barcode and QR code for medication guide and prescribing information.*

FDA Label Image

500 mg Divalproex Tablet Blister 8.jpg (500 mg Divalproex Tablet Blister 8)

Multiple small labels for Divalproex Sodium Extended-release Tablet, USP 500 mg, film-coated, oral dosage form. Each label includes the active ingredient name, strength, barcodes, lot number and expiry placeholders, and the American Health Packaging labeler information. The labels also feature a large stylized letter A logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.